The role of stratifin in fibroblast-keratinocyte interaction

Molecular and Cellular Biochemistry

Volumn 305, Issue 1-2, 2007, Pages 255-264

  Medina, Abelardo ^a   Ghaffari, Abdi ^a   Kilani, Ruhangiz T ^a   Ghahary, Aziz ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JACK BELL RESEARCH CENTRE   (Canada)

Author keywords

14 3 3 proteins; Fibroblasts keratinocyte; MMP 1expression; Stratifin; Wound healing

Indexed keywords

INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 24; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTROPHIL COLLAGENASE; PROTEIN 14 3 3; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P53; STRATIFIN; STROMELYSIN; STROMELYSIN 2; UNCLASSIFIED DRUG;

CELL INTERACTION; EPIDERMIS; GENE OVEREXPRESSION; HUMAN; HYPERTROPHIC SKIN DISEASE; KELOID; KERATINOCYTE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; SKIN FIBROBLAST; SKIN FIBROSIS; WOUND HEALING;

ANIMALS; CELL COMMUNICATION; EPIDERMIS; EXONUCLEASES; FIBROBLASTS; GENE EXPRESSION; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASE 1; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL; WOUND HEALING;

EID: 34948894991     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9538-y     Document Type: Review

References (107)

1. Moore BW, Perez VJ (1967) Specific acidic proteins of the nervous system. In: Carlson FD (ed) Physiological and biochemical aspects of nervous integration. Prentice-Hall, Englewood Cliffs, NJ, pp 343-359
2. 2+, calmodulin-dependent protein kinase II. FEB 219(1):79-82
3. Ichimura T, Isobe T, Okuyama T et al (1988) Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. Proc Natl Acad Sci USA 85:7084-7088
4. Fu H, Subramanian R, Masters S (2000) 14-3-3 proteins: Structure, function, and regulation. Annu Rev Pharmacol Toxicol 40:617-647
5. Muslin A, Tanner W, Allen P et al (1996) Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84:889-897
6. Aitken A (1996) 14-3-3 and its possible role in co-ordinating multiple signaling pathways. Cell Biology 6:341-347
7. Yaffe M, Rittinger K, Volinia S et al (1997) The structural basis for 14-3-3: Phosphopeptide binding specificity. Cell 91:961-971
8. Jin J, Smith D, Stark C et al (2004) Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 14:1436-1450
9. Mackintosh C (2004) Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem J 381:329-342
10. Yaffe M (2002) How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett 513:53-57
11. 2/M regulator 14-3-3σ prevents apoptosis through sequestration of Bax. J Biol Chem 276(48):45201-45206
12. Nomura M, Shimizu S, Sugiyama T et al (2003) 14-3-3 interacts directly with and negatively regulates pro-apoptotic bax. J Biol Chem 278(3):2058-2065
13. Petosa C, Masters S, Bankston L et al (1998) 14-3-3 ζ binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J Biol Chem 273:16305-16310
14. Benton R, Palacios I, St Johnston D (2002) Drosophila 14-3-3/PAR-5 is an essential mediator of PAR-1 function in axis formation. Dev Cell 3:659-671
15. Ferguson A, Evron E, Umbricht C et al (2000) High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97(11):6049-6054
16. Iwata N, Yamamoto H, Sasaki S et al (2000) Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3σ gene in human hepatocellular carcinoma. Oncogene 19:5298-5302
17. Suzuki H, Itoh F, Toyota M et al (2000) Inactivation of the 14-3-3 σ gene is associated with 5′ CpG island hypermethylation in human cancers. Cancer Res 60(16):4353-4357
18. Wang A, Kruhlak M, Wu J et al (2000) Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol Cell Biol 20(18):6904-6912
19. Grozinger CM, Schreiber SL (2000) Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci USA 97(14):7835-7840
20. Muratake T, Hayashi S, Ichikawa T et al (1996) Structural organization and chromosomal assignment of the human 14-3-3 eta chain gene (YWHAH). Genomics 36(1):63-69
21. 2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25 on Serine-216. Science 277:1501-1505
22. Dalal S, Schweitzer C, Gan J et al (1999) Cytoplasmic localization of human cdc25 during interphase requires an intact 14-3-3 binding site. Mol Cell Biol 19(6):4465-4479
23. Piwnica-Worms H (1999) Fools rush in. Nature 401:535-537
24. Chan T, Hermeking H, Lengauer C et al (1999) 14-3-3 σ is required to prevent mitotic catastrophe after DNA damage. Nature 401:616-620
25. Fantl WJ, Muslin AJ, Kikuchi A et al (1994) Activation of Raf-1 by 14-3-3 proteins. Nature 371:612-614
26. Fu H, Xia K, Pallas DC et al (1994) Interaction of the protein kinase Raf-1 with 14-3-3 proteins. Science 266:126-129
27. Fanger GR, Widmann C, Porter AC et al (1998) 14-3-3 proteins interact with specific MEK kinases. J Biol Chem 273:3476-3483
28. Kosaki A, Yamada K, Suga J et al (1998) 14-3-3beta protein associates with insulin receptor substrate 1 and decreases insulin-stimulated phosphatidylinositol 3′-kinase activity in 3T3L1 adipocytes. J Biol Chem 273(2):940-944
29. Bonnefoy-Berard N, Liu YC, von Willebrand M et al (1995) Inhibition of phosphstidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. Proc Natl Acad Sci USA 92(22):10142-10146
30. Zha J, Haraa H, Yang E et al (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87(4):619-628
31. Tan Y, Demeter M, Ruan H et al (2000) BAD ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J Biol Chem 275(33):25865-25869
32. Masters S, Yang H, Datta S et al (2001) 14-3-3 inhibits bad-induced cell death through interaction with serine-136. Mol Pharmacol 60(6):1325-1331
33. Tsuruta F, Sunayama J, Mori Y et al (2004) JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 23(8):1889-1899
34. Zhang L, Chen J, Fu H (1999) Supression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci USA 96(15):8511-8515
35. Masters S, Subramanian R, Truong A et al (2002) Survival-promoting functions of 14-3-3 proteins. Biochem Soc Trans 30(4):360-365
36. Beguin P, Mahalakshmi RN, Nagashima K et al (2005) 14-3-3 and calmodulin control Subcellular distribution of Kir/Gem and its regulation of cell shape and calcium channel activity. J Cell Sci 118:1923-1934
37. Liao J, Omary B (1996) 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor. J Cell Biol 133(2):345-357
38. Ku N-O, Michie S, Resurreccion E et al (2002) Keratin binding to 14-3-3 protein modulates keratin filaments and hepatocyte mitotic progression. Proc Natl Acad Sci USA 99(7):4373-4378
39. Roth D, Birkenfeld J, Betz H (1999) Dominant-negative alleles of 14-3-3 proteins cause defects in actin organization and vesicle targeting in the yeast Saccharomyces cerevisiae. FEBS Lett 460(3):411-416
40. Morgan A, Burgoyne RD (1992) Exo1 and Exo2 proteins stimulate calcium-dependent Exocytosis in permeabilized adrenal chromaffin cells. Nature 355(27):833-836
41. Dellambra E, Golisano O, Bondanza S et al (2000) Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol 149(5):1117-1129
42. Tzivion G, Luo Z, Avruch J (1998) A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394:88-92
43. Avruch J, Khokhlatchev A, Kyriakis J et al (2001) Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog Horm Res 56:127-155
44. Kaneko K, Hachiya NS (2006) The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions. Med Hypotheses 67(1):169-171
45. Urano T, Saito T, Tsukui T et al (2002) Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth. Nature 417:871-875
46. Nakayama H, Sano T, Motegi A et al (2005) Increasing 14-3-3 sigma expression with declining estrogen receptor α and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma. Pathol Int 55(11):707-715
47. Sato S, Chiba T, Sakata E et al (2006) 14-3-3 eta is a novel regulator of parkin ubiquitin ligase. EMBO J 25(1):211-221
48. Laronga C, Yang H-Y, Neal C et al (2000) Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 275(30):23106-23112
49. Stavridi E, Chehab N, Malikzay A et al (2001) Substitutions that compromise the ionizing radiation-induced association of p53 with 14-3-3 proteins also compromise the ability of p53 to induce cell cycle arrest. Cancer Res 61:7030-7033
50. Hermeking H (2003) The 14-3-3 cancer connection. Nat Rev Cancer 3:931-943
51. Moreira J, Gromov P, Celis J (2004) Expression of the tumor suppressor protein 14-3-3σ is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition. Mol Cell Proteomics 3(4):410-419
52. Wang W, Shakes D (1997) Expression patterns and transcript processing of ftt-1 and ftt-2, two C. elegans 14-3-3 homologues. J Mol Biol 268:619-630
53. Morton D, Shakes D, Nugent S et al (2002) The Caenorhabditis elegans par-5 gene encodes a 14-3-3 protein requires for asymmetry in the early embryo. Dev Biol 241:47-58
54. Benton R, St Johnston D (2003) Drosophila PAR-1 and 14-3-3 inhibit Bazzoka/PAR-3 to establish complementary cortical domains in polarized cells. Cell 115:691-704
55. Freed E, Symons M, Macdonald SG et al (1994) Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science 265:1713-1716
56. Powell DW, Rane MJ, Chen Q et al (2002) Identification of 14-3-3zeta as a protein kinase B? Akt substrate. J Biol Chem 277:21639-21642
57. Sunayama J, Tsuruta F, Masuyama N et al (2005) JNK antagonizes Akt-mediated survival signals by phophorylating 14-3-3. J Cell Biol 170(2):295-304
58. Furlanetto R, Dey B, Lopaczynski W et al (1997) 14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor. Biochem J 327:765-771
59. Peruzzi F, Prisco M, Dews M et al (1999) Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19(10):7203-7215
60. Craparo A, Freund R, Gustafson T (1997) 14-3-3 (ε) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J Biol Chem 272(17):11663-11669
61. Parvaresch S, Yesilkaya T, Baer K et al (2002) 14-3-3 binding to the IGF-1 receptor is mediated by serine autophosphorylation. FEBS Lett 532:357-362
62. Wakui H, Wright AP, Gustafsson J et al (1997) Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein. J Biol Chem 272(13):8153-8156
63. Tzivion G, Luo Z-J, Avruch J (2000) Calyculin A-induced Vimentin phosphorylation sequesters 14-3-3 and displaces other 14-3-3 partners in vivo. J Biol Chem 275(38):29772-29778
64. Hermeking H, Lengauer C, Polyak K et al (1997) 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1:3-11
65. Conklin DS, Galaktionov K, Beach D (1995) 14-3-3 proteins associate with cdc25 phosphatases. Proc Natl Acad Sci USA 92:7892-7896
66. Fujita N, Sato S, Katayama K et al (2002) Akt-dependent phosphorylation of p27 Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem 277(32):28706-28713
67. Honda R, Ohba Y, Yasuda H (1997) 14-3-3ζ protein binds to the carboxyl half of mouse wee1 kinase. Biochem Biophys Res Commun 230:262-265
68. Lee J, Kumagai A, Dunphy WG (2001) Positive regulation of wee1 by chk1 and 14-3-3 proteins. Mol Biol Cell 12:551-563
69. 2-M cell population. Cell Growth Differ 11:211-219
70. Yang A, McKeon F (2000) P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 1(3):199-207
71. Yang A, Kaghad M, Caput D et al (2002) On the shoulders of giants: P63, p73 and the rise of p53. Trends Genet 18(2):90-95
72. Westfall M, Mays D, Sniezek J et al (2003) The ΔNp63α phosphoprotein binds the p21 and 14-3-3σ promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells Syndrome-derived mutations. Mol Cell Biol 23(7):2264-2276
73. Pellegrini G, Dellambra E, Golisano O et al (2001) p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 98(6):3156-3161
74. Yang A, Schweitzer R, Sun D et al (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-718
75. Mills A, Zheng B, Wang X-J et al (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713
76. McGrath J, Duijf P, Doetsch V et al (2001) Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum Mol Genet 10(3):221-229
77. Celli J, Duijf P, Hamel B et al (1999) Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99:143-153
78. Satoh J-I, Kurohara K, Yukitake M et al (1999) The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol 41:216-225
79. Siman R, McIntosh T, Soltesz K et al (2004) Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis 16(2):311-320
80. Leffers H, Madsen P, Rasmussen H et al (1993) Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. J Mol Biol 231:982-998
81. Aitken A (1995) 14-3-3 proteins on the MAP. Trends Biochem Sci 20:95-97
82. Ghahary A, Karimi-Busheri F, Marcoux Y et al (2004) Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol 122:1188-1197
83. Ghahary A, Marcoux Y, Karimi-Busheri F et al (2005) Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 124:170-177
84. Lam E, Kilani R, Li Y et al (2005) Stratifin-induced matriz metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation. J Invest Dermatol 125:230-238
85. Lam E, Tredget E, Marcoux Y et al (2004) Insulin suppresses collagenase stimulatory effect of stratifin in dermal fibroblasts. Mol Cell Biochem 266:167-174
86. Westermarck J, Kahari V-M (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB 13:781-792
87. Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20:2390-2400
88. Minden A, Karin M (1997) Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1333:F85-F104
89. Chai J, Tarnawski A (2002) Serum response factor: Discovery, biochemistry, biological roles and implications for tissue injury healing. J Physiol Pharmacol 53(2):147-157
90. Buchwalter G, Gross C, Wasylyk B (2004) Ets ternary complex transcription factors. Gene 324:1-14
91. Sharrocks AD (2002) Complexities in ETS-domain transcription factor function and regulation: Lessons from the TCF (ternary complex factor) subfamily. Biochem Soc Trans 30:1-9
92. Mo Y, Vaessen B, Johnston K et al (1998) Structures of SAP-1 bound to DNA targets from the E74 and c-fos promoters: Insights into DNA sequence discrimination by Ets proteins. Mol Cell 2(2):210-212
93. Dalton S, Treisman R (1992) Characterization of SAP-1, a protein recruited by serum response factor to the c-Fos serum response element. Cell 68:597-612
94. Giovane A, Sobieszczuk P, Ayadi A et al (1997) Net-b, a Ras-insensitive factor that forms ternary complexes with serum response factor on the serum response element of the fos promoter. Mol Cell Biol 17(10):5667-5678
95. Janknecht R, Hunter T (1997) Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J 16(7):1620-1627
96. Galanis A, Yang S-H, Sharrocks A (2001) Selective targeting of MAPKs to the ETS domain transcription factor SAP-1. J Biol Chem 276(2):965-973
97. Martin P (1997) Wound healing. Aiming for perfect skin regeneration. Science 276:75-81
98. Kerkela E, Saarialho-Kere U (2003) Matrix metalloproteinases in tumor progression: Focus on basal and squamous cell skin cancer. Exp Dermatol 12:109-125
99. Scott PG, Ghahary A, Tredget EE (2000) Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 16:271-287
100. Tredget EE, Nedelec B, Scott PG et al (1997) Hypertrophic scars, keloids, and contractres. The cellular and molecular basis for therapy. Surg Clin North Am 77:701-730
101. Deitch EA, Wheelahan TM, Rose MP et al (1983) Hypertrophic burn scars: analysis of variables. J Trauma 23:895-898
102. Mackay AR, Ballin M, Pelina MD et al (1992) Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invas Metast 12:168-184
103. Moon SE, Dame MK, Remick DR et al (2001) Induction of matrix metalloproteinase-1 (MMP-1) during epidermal invasion of the stroma in human skin organ culture: Keratinocyte stimulation of fibroblasts MMP-1 production. Br J Cancer 85:1600-1605
104. Stoll S, Garner W, Elder J (1997) Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture. J Clin Invest 100:1271-1281
105. Maas-Szabowski N, Stark HJ, Fusenig NE (2000) Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 114:1075-1084
106. Ghaffari A, Li Y, Karami A et al (2006) Fibroblast extrcellular matrix gene expression in response to keratinocyte-releasable stratifin. J Cell Biochem 98:383-393
107. Moon SE, Bhagavathula N, Varani J (2002) Keratinocyte stimulation of matrix metalloproteinase-1 production and proliferation in fibroblasts: regulation through mitogen-activated protein kinase signalling events. Br J Cancer 87:457-464